SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - North America EU edition | APAC edition

News > Regulation

Cancer claims are a big red flag that some marketers continue to wave

Like the poor, it seems for the dietary supplement industry cancer treatment claims will ever be with us. 

Are barriers for hemp cultivation going down? New report documents industrial hemp legislative progress in US

Last year saw the addition of four new ‘Hemp States’ (Florida, Alabama, Pennsylvania, Rhode Island), according to Vote Hemp’s 2016 States Report.

Expert questions role of synthetic ingredients in an industry that bills itself as ‘natural’

For one expert the question of so called synthetic botanicals goes deeper than whether they are legal. It’s a question that drives to the core of what the dietary supplement...

Warning letter highlights importance of detailed quality agreements

The importance of having a detailed quality agreement with your contract manufacturer has been driven home by a recent warning letter issued to a marketer of sports nutrition products.

NDI guidance would over regulate, weaken supplement industry, Jarrow asserts

The updated New Dietary Ingredients draft guidance is an attempt to over regulate and weaken the dietary supplement industry with no increase in public safety, according to comments filed recently...

2016: The year of the hammer and the squeeze

2016 felt like the year of hammer blows and the squeeze play, with the finale the unpredicted win of Donald Trump as President. I count myself among those who close...

NPA chief recounts actions on vinpocetine, Puerto Rico regs and other challenges

NPA chief Dan Fabricant recounts his association's efforts on behalf of industry in 2016.

NAXA chief on trust: It’s the highest asset to which the industry can aspire

At this time of year, many of us take advantage of the changing calendar and assess where we are as an industry. Typically, this exercise is a broad-based reflection evaluating...

Trump, vinpocetine, hemp: AHPA looks at 2016 events that will affect 2017

Several events in 2016 will impact the industry in 2017 and future years. The 2016 election results tops that list. Like most other industries in the U.S., the herbal products...

Sen McCaskill calls on FDA to quickly finalize NDI guidance

Senator Claire McCaskill (D-MO) is frustrated with bureaucratic delays to the New Dietary Ingredient (NDI) draft guidance, and is calling on the FDA to quickly finalize the document.

UNPA brands FDA's finished product focus in NDI guidance as unworkable and unlawful

Requiring NDI notifications on almost every new product will create a situation in which few companies will be able to comply with the new draft guidance, the United Natural Products...

IPA recommends expanded grandfathered list for probiotics

The International Probiotics Association has urged the FDA to expanded the ‘grandfathered list’ dietary ingredients to include bacterial strains globally recognized as used historically in foods.

FDA approves qualified health claim for high-amylose resistant starch and reduced risk of type 2 diabetes

News that the US Food and Drug Administration (FDA) has approved a qualified health claim about high amylose maize resistant starch as a weapon in the fight against type 2...

NDI draft guidance needs extensive revision, AHPA asserts

The current NDI draft guidance is unlikely to improve compliance or the quality of submissions and should be rewritten. That’s the opinion expressed by the American Herbal Products Association in...

NPA urges FDA to back off in applying food additive standards

The Natural Products Association has urged FDA to cease its attempt to apply  food additive standards to dietary ingredients. To do so would create an undue burden on small business,...

CRN asks FDA to broaden its view of what constitutes a dietary ingredient

The Council for Responsible Nutrition has urged the Food and Drug Administration to broaden the definition of dietary ingredients in its NDI draft guidance and to step back from requiring...

First take on NDI comments: Guidance will stifle innovation without increase in safety

Comments on FDA’s NDI guidance have flooded in, and several themes have emerged. Commenters observed that the guidance will stifle competition, is overburdensome and will contribute little to the overall...

Experts recommend kratom & CBD players file NDIs first, before asking for new product category

Some proponents of botanicals such as kratom or CBDs have chafed under regulatory restrictions that have forestalled wider acceptance and availability. But the full market is potentially available for those...

FDA open to notion that new fermentation medium doesn't change probiotic identity, expert says

A recent presentation to FDA that was well received made the case that simple changes in fermentation media would not result in the creation of a New Dietary Ingredient.

GNC agrees to DOJ plan for greater product surveillance to settle USP Labs issue

Retailing giant GNC has entered into an wide-ranging agreement with the Department of Justice aimed at preventing potentially unlawful ingredients and supplements from showing up on its shelves.

FDA releases adverse events data for supplements, foods, and cosmetics

Motivated by transparency, the US Food and Drug Administration has released tens of thousands of adverse event reports for dietary supplements, but does the data actually allow for any conclusions...

FDA offers guidance on how to determine fiber status of prebiotic ingredients

In a recently issued draft guidance, the Food and Drug Administration has shed more light on the process of determining what’s a fiber and what might not be—information that could...

ABC, AHPA urge officials to refrain from banning kratom constituents

The American Botanical Council and the American Herbal Products Association have urged the DEA to back off its plan to ban kratom. The groups took slightly different tacks in their...

Drug expert says FDA, not DEA, should oversee kratom as herb poses little public health risk

Kratom should not be a controlled substance because it poses little risk for abuse and dependance, according to a drug expert whose analysis was commissioned by an advocacy group.

NPA tells DEA that Kratom poses threat to public health

Adding kratom to the US food supply could lead to serious unintended consequences as the US struggles with opioid addiction, says the Natural Products Association in comments submitted to the...

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...